Lifestyle
- Regular moderate exercise
- Adequate sleep
- Stress management
Neutrophils · PMN · Neutrophile Granulozyten
Neutrophil count measures the number of neutrophils, a type of white blood cell, in the blood.
Reference ranges can vary based on age and laboratory standards.
Neutrophils, also known as neutrophile granulocytes or polymorphonuclear leukocytes (PMNs), are a type of white blood cell crucial for the body's defense against infections. They are the most abundant type of granulocytes and play a key role in the innate immune response by engulfing and destroying pathogens through phagocytosis. Neutrophils are produced in the bone marrow and released into the bloodstream, where they circulate and respond to signals of infection or inflammation. Clinically, neutrophil levels are significant indicators of various health conditions. Elevated neutrophil counts, or neutrophilia, can indicate acute bacterial infections, inflammation, or stress, while low counts, or neutropenia, may suggest bone marrow disorders, severe infections, or the effects of certain medications. In cancer patients, a high neutrophil-to-lymphocyte ratio is associated with poor prognosis. For athletes and biohackers, monitoring neutrophil levels can provide insights into immune function and recovery status. High-intensity exercise can temporarily increase neutrophil counts, reflecting acute stress and inflammation. However, chronic elevation may indicate overtraining or insufficient recovery. It is important to consider that neutrophil levels can be influenced by various factors, including time of day, recent infections, and medications. Fasting is not required for testing, but samples should be collected at consistent times to avoid diurnal variations. Researchers have observed that neutrophil levels peak in the afternoon, which may affect interpretation if not standardized. Understanding these variables is essential for accurate assessment and interpretation of neutrophil counts.
Klinische Bedeutung
Elevated neutrophil levels may indicate bacterial infections, inflammation, or stress. Reduced levels can suggest bone marrow disorders, severe infections, or effects of certain medications.
Progressively rising neutrophil levels may suggest ongoing infection or inflammation. Re-test in 4 weeks if outside optimal range.
Progressively falling levels may indicate bone marrow suppression or recovery from infection.
Re-test Interval
4 weeks if outside optimal range
Note:
Consult a healthcare provider before making significant lifestyle or dietary changes, especially if underlying medical conditions are present.
Neutrophil levels peak in the afternoon; consistent timing is recommended for comparability.
Testing Frequency
Annually for healthy adults, more frequently if monitoring specific conditions.
Current research suggests that the predictive value of tumour-associated neutrophils (TANs) remains debated, with conflicting data across cancer types and uncertainties regarding their optimal location within tumors. Researchers have not yet established clear reference ranges for neutrophil subtypes as biomarkers in immunotherapy response, particularly in diverse patient populations. Additionally, clinical questions remain unanswered regarding the mechanisms by which neutrophil phenotypes influence treatment efficacy and disease progression in various cancers and autoimmune conditions.
1,917
Total Citations
7
Human/RCT
6.9
Avg. Influence
2025
Latest
Researchers found that neutrophils accumulate in the blood of cancer patients, particularly those with advanced disease. A high neutrophil-to-lymphocyte ratio serves as a strong indicator of poor clinical outcomes across various cancers. The study also discusses the potential roles of tumor-associated neutrophils in cancer progression and treatment response.
Researchers discussed the role of neutrophils in cancer progression, noting their involvement in angiogenesis and metastasis. The study suggests that the neutrophil-to-lymphocyte ratio could serve as a biomarker for cancer status and highlights the potential of neutrophils as therapeutic targets.
Researchers identified interferon-stimulated Ly6Ehi neutrophils as a blood biomarker that can predict responses to anti-PD1 immunotherapy in cancer patients. The study demonstrated high accuracy in predicting treatment response in both mice and human cohorts. This finding emphasizes the potential for using neutrophils as functional biomarkers in immunotherapy.
This review highlighted the role of neutrophil extracellular traps (NETs) in stroke, noting their dual function in trapping pathogens and exacerbating inflammation. Researchers summarized mechanisms of NET formation and their contributions to stroke pathology, suggesting that targeting NETs could be a novel therapeutic approach.
This study examined the role of autoantibodies in membranous nephropathy, a kidney disease. Researchers found that the presence of specific autoantibodies correlates with disease severity and can serve as biomarkers for monitoring progression and treatment response. The study also highlights emerging factors associated with the disease.
This review highlights the roles of neutrophils and platelets in neuroinflammatory diseases. Researchers found that interactions between these cells contribute to neuroinflammation and the disruption of brain barriers. The study emphasizes the potential for targeting these interactions to develop new treatments for neurological disorders.
This study examined the role of neutrophils as potential biomarkers and therapeutic targets in radiation therapy for cancer. Researchers found a strong correlation between baseline blood neutrophil counts and overall survival in patients undergoing radiation, suggesting their predictive value.
This review discusses anti-neutrophil cytoplasmic antibodies (ANCA) as biomarkers for systemic small-vessel vasculitis. Researchers explain the different staining patterns of ANCA and their clinical significance in diagnosing various forms of vasculitis.
This study explored the interaction between bladder cancer cells and neutrophils, revealing that cancer cells recruit neutrophils through IL-8 secretion. Researchers found that urine IL-8 is a better biomarker for bladder cancer prognosis than serum IL-8, suggesting new avenues for treatment strategies.
This review examined the role of neutrophils in pulmonary fibrosis, noting their increased presence in patients with interstitial lung diseases. Researchers highlighted the potential of neutrophils as biomarkers for disease severity and emphasized the need for further investigation into their dual roles in lung tissue.
5
Total Trials
886
Total Enrolled
Aristotle University Of Thessaloniki
45
2025
Neutrophil Gelatinase-Associated Lipocalin
Muğla Sıtkı Koçman University
35
2022
Early inflammation markers for VAP
Loyola University
42
2021
Urinary neutrophil gelatinase-associated lipocalin (NGAL)
University of Pennsylvania
704
2010
Composite of i) All-cause Mortality or ii) End-stage Renal Disease
University Hospital Dubrava
60
2008
Neutrophil activity before and after the open or laparoscopic surgery - Serum concentrations of sFas, sFasL and IL - 17.
Research publications about Neutrophile over time
10totalLog lab results, track trends and optimize your biomarkers over time.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer